Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 2:13 PM
Ignite Modification Date: 2025-12-24 @ 2:13 PM
NCT ID: NCT01275495
Eligibility Criteria: Inclusion Criteria: * Primary caregiver (unpaid family member or significant other) of a stroke survivor * No more than 8 weeks after survivor discharged home * Plans to be providing care for 1 year or longer * Access to a telephone * Willingness to participate in 9 calls from a nurse and 5 data collection interviews at designated study time points Exclusion Criteria: * Caregiver or survivor age \< 21 years * Caregiver denies that survivor has had a stroke * Caregiver does not consider him or herself a caregiver, stating that the survivor is not impaired or is the same as before the stroke * Caregiver has low task difficulty (OCBS task difficulty score \< 16) * Caregiver communication difficulties (e.g., hearing loss) * Caregiver not fluent in the English language * Caregiver 6-item MMSE score less than 4 * Survivor residing in a nursing home or long-term care facility * Survivor or caregiver has a terminal illness (e.g., cancer, end of life condition with decreased life expectancy, renal failure requiring dialysis) * Survivor or caregiver history of hospitalization for alcohol or drug abuse * Survivor or caregiver history of severe mental illness (e.g., Alzheimer's, dementia, suicidal tendencies, severe untreated depression or manic depressive disorder, schizophrenia) * Survivor or caregiver pregnancy * Survivor or caregiver is a prisoner or on house arrest
Healthy Volunteers: True
Sex: ALL
Minimum Age: 21 Years
Study: NCT01275495
Study Brief:
Protocol Section: NCT01275495